Concepedia

Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells

Raimond Heukers, Roy van der Meel, M. Lacombe, Maryam Amidi, Paul M.P. van Bergen en Henegouwen, Wim E. Hennink, Raymond M. Schiffelers, Robbert J. Kok

Journal of Controlled Release · 2012 · 113 citations · 35 references

DOI

Concepts

References

35

Optimization of the preparation process for human serum albumin (HSA) nanoparticles

Klaus Langer, Sabine Balthasar, Vitali Vogel et al. · International Journal of Pharmaceutics · 2003 · 753 citations

, , +12

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles

S. Dreis, Florian Rothweiler, Martin Michaelis et al. · International Journal of Pharmaceutics · 2007 · 274 citations

, , +14

Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin

Marina Talelli, Maryam Iman, Amir K. Varkouhi et al. · Biomaterials · 2010 · 263 citations

, , +14

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

Jörg Kreuter, Telli Hekmatara, S. Dreis et al. · Journal of Controlled Release · 2006 · 260 citations

, , +12

Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation

Klaus Langer, Marion G. Anhorn, I Steinhauser et al. · International Journal of Pharmaceutics · 2007 · 255 citations

, , +16